Medpace Holdings, Inc.
MEDP
$428.03
$11.992.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 708.45M | 659.90M | 603.31M | 558.57M | 536.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 708.45M | 659.90M | 603.31M | 558.57M | 536.59M |
| Cost of Revenue | 182.15M | 186.34M | 185.83M | 177.82M | 167.52M |
| Gross Profit | 526.30M | 473.57M | 417.49M | 380.75M | 369.07M |
| SG&A Expenses | 44.92M | 48.08M | 46.66M | 57.90M | 45.43M |
| Depreciation & Amortization | 7.13M | 7.05M | 7.01M | 6.93M | 7.51M |
| Other Operating Expenses | 320.98M | 276.63M | 237.47M | 202.40M | 190.75M |
| Total Operating Expenses | 555.18M | 518.10M | 476.98M | 445.05M | 411.21M |
| Operating Income | 153.27M | 141.81M | 126.34M | 113.52M | 125.38M |
| Income Before Tax | 156.83M | 142.84M | 124.54M | 118.17M | 133.88M |
| Income Tax Expenses | 21.70M | 31.70M | 34.28M | 3.58M | 16.86M |
| Earnings from Continuing Operations | 135.13M | 111.14M | 90.26M | 114.60M | 117.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 135.13M | 111.14M | 90.26M | 114.60M | 117.02M |
| EBIT | 153.27M | 141.81M | 126.34M | 113.52M | 125.38M |
| EBITDA | 160.40M | 148.86M | 133.35M | 120.45M | 132.88M |
| EPS Basic | 4.78 | 3.95 | 3.16 | 3.77 | 3.78 |
| Normalized Basic EPS | 3.46 | 3.17 | 2.72 | 2.43 | 2.70 |
| EPS Diluted | 4.66 | 3.86 | 3.10 | 3.67 | 3.67 |
| Normalized Diluted EPS | 3.38 | 3.10 | 2.67 | 2.37 | 2.63 |
| Average Basic Shares Outstanding | 28.29M | 28.14M | 28.60M | 30.39M | 30.95M |
| Average Diluted Shares Outstanding | 28.96M | 28.82M | 29.14M | 31.20M | 31.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |